KYMAB LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 7267
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 45210
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS3915
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 23144
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 9116
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 891
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 6200
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1106

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0327,586 SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHDJul 27, 17Nov 16, 17[A61K, G01N, C07K]
2017/0327,587 ANTIBODIES, USES & METHODSJul 27, 17Nov 16, 17[A61K, C07K]
2017/0319,689 Methods, Regimens, Combinations & AntagonistsJun 01, 17Nov 09, 17[A61K, C07K]
2017/0320,956 ANTI-LIGHT ANTIBODIESJun 16, 17Nov 09, 17[C12N, C07K]
2017/0306,013 SELECTIVE NAV PROTEIN BINDERSOct 20, 15Oct 26, 17[A61K, C07K]
2017/0275,611 METHODS, CELLS & ORGANISMSMay 31, 17Sep 28, 17[C12N, A01K, C07K]
2017/0260,279 SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHDMay 24, 17Sep 14, 17[A61K, G01N, C07K]
2017/0099,815 Animal Models and Therapeutic MoleculesDec 19, 16Apr 13, 17[A01K, C07K]
2017/0101,482 Animal Models and Therapeutic MoleculesDec 19, 16Apr 13, 17[A01K, C07K]
2017/0044,250 Antibodies, Uses & MethodsNov 01, 16Feb 16, 17[C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914769 Precision medicine for cholesterol treatmentJul 15, 14Mar 13, 18[A61K, C12Q, A61F, A61N, C07K]
9896516 Animal models and therapeutic moleculesApr 11, 16Feb 20, 18[C12P, C12N, A01K, C07K]
9868789 Synergistic combinations of OX40L antibodies for the treatment of GvHDMay 24, 17Jan 16, 18[A61K, G01N, C07K]
9868790 Synergistic combinations of OX40L antibodies for the treatment of GvHDJul 27, 17Jan 16, 18[A61K, G01N, C07K]
9788534 Animal models and therapeutic moleculesMar 18, 13Oct 17, 17[C07H, C12N, A01K, C07K]
9783593 Antibodies, variable domains and chains tailored for human useMay 02, 13Oct 10, 17[C12P, C12N, A01K, C07K]
9783618 Manipulation of immunoglobulin gene diversity and multi-antibody therapeuticsMar 19, 14Oct 10, 17[C12P, C12N, G01N, C07K]
9617338 Antibodies and immunocytokinesNov 17, 16Apr 11, 17[A61K, C07K]
9587030 Anti-hOX40L antibodies, uses, and methodsSep 08, 16Mar 07, 17[A61K, C07K]
9567399 Antibodies and immunocytokinesJul 15, 16Feb 14, 17[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0177,340 Methods, Cells & OrganismsAbandonedMar 07, 16Jun 23, 16[C12N]
9290566 Transgenic mouse homozygous for chimeric IgH locusWithdrawnMar 09, 12Mar 22, 16[C12N, A01K, C07K]
2015/0079,680 METHODS, CELLS & ORGANISMSAbandonedSep 18, 14Mar 19, 15[C12N]
2015/0033,372 Human VpreB & Chimaeric Surrogate Light Chains in Transgenic Non-Human VertebratesAbandonedMar 26, 14Jan 29, 15[C12P, C12N, A01K, C07K]
2014/0041,067 ANTIBODIES, VARIABLE DOMAINS & CHAINS TAILORED FOR HUMAN USEAbandonedOct 11, 13Feb 06, 14[A01K]
2013/0347,138 Cells and Vertebrates for Enhanced Somatic Hypermutation and Class Switch RecombinationAbandonedMay 08, 13Dec 26, 13[A01K]
2013/0243,759 Transgenic AnimalsAbandonedMar 15, 13Sep 19, 13[A01K, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.